Multicentre audit of the use of drotrecogin alfa (activated) in UK critical care units

被引：0
|
作者：
K Rowan
C Welch
E North
D Harrison
机构：
[1] Intensive Care National Audit & Research Centre,
[2] ,undefined
来源：
Critical Care | / 11卷 / Suppl 2期
关键词：
Severe Sepsis; Organ Dysfunction; Hospital Mortality; Data Collection Form; Critical Care Unit;
D O I：
10.1186/cc5216
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [11] One-year analysis of prescriptions of drotrecogin alfa (activated) in medical and surgical intensive care units
    Schlecht, Deborah
    Dallay, Stephanie
    Bauer, Sebastien
    Ferrandiere, Martine
    Grassin, Jacqueline
    Antier, Daniel
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 458 - 458
  • [12] Experience with drotrecogin alfa activated (DAA) in a tertiary care hospital
    Wittbrodt, E
    Rose, C
    CRITICAL CARE MEDICINE, 2002, 30 (12) : A104 - A104
  • [13] Drotrecogin alfa (activated): From bench to practical use at the bedside
    Rodriguez, J
    AMERICAN JOURNAL OF SURGERY, 2002, 184 (6A): : 1S - 2S
  • [14] Use of drotrecogin alfa activated in septic AIDS patients.
    Rowden, AM
    PHARMACOTHERAPY, 2004, 24 (10): : 1429 - 1429
  • [15] Use of drotrecogin alfa (activated) in older patients with severe sepsis
    Alexander, SL
    Ernst, FR
    PHARMACOTHERAPY, 2006, 26 (04): : 533 - 538
  • [16] Impact of drotrecogin alfa (activated) on resource use and implications for reimbursement
    Dasta, JF
    Cooper, LM
    PHARMACOTHERAPY, 2002, 22 (12): : 216S - 222S
  • [17] Cost-effectiveness of drotrecogin alfa (activated) in treating severe sepsis in the UK
    Davies, A
    Hutton, J
    Ridley, S
    Chinn, C
    Barber, B
    INTENSIVE CARE MEDICINE, 2002, 28 : S161 - S161
  • [18] Strategies to optimize drotrecogin alfa (activated) use: Guidelines and therapeutic controversies
    Cohen, H
    Welage, LS
    PHARMACOTHERAPY, 2002, 22 (12): : 223S - 235S
  • [19] The use of drotrecogin alfa (activated) in a patient with recent orthotopic liver transplant
    Browne, E.
    Cressey, D. M.
    Agarwal, K.
    Cosgrove, J. F.
    ANAESTHESIA, 2007, 62 (03) : 282 - 285
  • [20] Drotrecogin alfa (activated) - A pharmacoeconomic review of its use in severe sepsis
    Frampton, JE
    Foster, RH
    PHARMACOECONOMICS, 2004, 22 (07) : 445 - 476
12345